polypeptid
vaccinia
viru
envelop
expos
surfac
identifi
mean
sulfonhydroxysuccinimidobiotin
surfac
tag
among
surfac
express
polypeptid
antigen
previous
design
monoclon
mab
monospecif
affin
pure
antibodi
direct
neutral
vaccinia
infecti
indic
promin
surfac
antigen
function
earli
virushost
cell
interact
bind
sever
monoclon
antibodi
variou
region
test
react
cnbr
fragment
deriv
polypeptid
employ
western
blot
mab
test
react
region
estim
molecular
weight
mw
base
migrat
cnbr
peptid
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
reveal
partial
digest
product
contain
prolinerich
amino
acid
limit
digest
fragment
present
posit
approxim
kda
larger
predict
dna
sequenc
contrast
partial
limit
digest
product
lack
pralinerich
fragment
migrat
mw
posit
expect
length
dna
sequenc
observ
demonstr
departur
predict
kda
anomal
mw
confer
prolinerich
peptid
surfac
locat
confirm
immun
electron
microscopi
competit
test
bind
specif
mab
affinitypurifi
antibodi
surfac
virion
could
demonstr
evid
associ
viru
envelop
variou
stage
biogenesi
vaccinia
obtain
immun
electron
microscopi
whole
mount
thin
section
presenc
earli
compon
immatur
matur
virion
probabl
resid
bilay
membran
structur
detect
distinct
therefor
made
sever
vaccinia
envelop
polypeptid
synthes
late
function
ad
late
stage
envelop
assembl
x
academ
press
inc
orthopoxvirus
exemplifi
vacciniaviru
subject
intens
studi
possess
great
structur
function
complex
follow
uniqu
scheme
replic
versatil
recombin
vector
transfer
foreign
gene
anim
cell
dale
pogo
fenner
stall
panicali
et
al
smith
et
orthopoxviru
replic
confin
cytoplasm
host
cell
mandat
encod
viru
larg
spectrum
enzymat
activ
initi
uncoat
transcript
event
review
dale
pogo
fenneret
morphogenesi
vaccinia
subdivid
tempor
regul
seri
stage
one
particular
area
interest
laboratori
biogenesi
vaccinia
viral
envelop
occur
uniqu
de
novo
mechan
within
viroplasm
matrix
also
term
factori
defin
envelop
membran
lipoprotein
tegument
enclos
virion
dale
pogo
unlik
situat
support
medic
research
council
canada
recipi
ontario
graduat
scholarship
membraneenclos
eukaryot
virus
format
vaccinia
envelop
connect
preexist
cellular
membran
dale
mosbach
first
step
envelop
assembl
evid
electron
microscopi
appear
curv
segment
consist
unit
membran
configur
back
extern
layer
spicul
provid
rigid
confer
spheric
shape
immatur
form
virion
dale
mosbach
earli
stage
envelop
format
occur
normal
absenc
viral
dna
synthesi
may
block
inhibitor
hydroxyurea
hu
pogo
dale
normal
morphogenesi
dna
synthesi
allow
occur
nucleoprotein
complex
packag
within
envelop
becom
differenti
characterist
biconcav
core
associ
later
bodi
late
stage
matur
viru
surfac
modifi
exchang
spicul
layer
coat
surfac
tubular
element
ste
stern
dale
essani
et
al
although
understand
date
format
vaccinia
envelop
rudimentari
known
mixtur
phospholipid
glycolipid
becom
incorpor
differ
composit
present
uninfect
cell
correspond
close
chang
composit
significantli
alter
infect
stern
dale
anderson
dale
concern
envelop
polypeptid
spicul
consist
polypeptid
accumul
larg
quantiti
earli
stage
infect
sarov
joklik
essani
et
al
littl
inform
avail
howev
protein
form
envelop
much
attent
current
focus
potenti
use
vaccinia
viru
recombin
effect
vaccin
wide
varieti
pathogen
review
mackett
smith
moss
flexner
piccini
paoletti
foreign
polypeptid
express
recombin
compartment
within
cell
accord
signal
sequenc
encod
gene
insert
becom
part
virion
analysi
vaccinia
envelop
polypeptid
may
identifi
structur
motif
within
polypeptid
role
envelop
assembl
furthermor
thorough
understand
antigen
compon
viral
envelop
bear
futur
develop
creat
safe
efficaci
vaccin
capabl
modul
host
immun
respons
circumv
major
limit
factor
revaccin
individu
vaccinia
recombin
one
promin
envelop
compon
matur
vaccinia
becom
antigen
signific
infect
anim
polypeptid
design
polypeptid
readili
solubil
nonion
deterg
wilton
et
al
identifi
earli
viru
function
synthes
dna
replic
stop
hu
gordon
etal
gene
encod
map
within
hindil
fragment
h
gordon
et
al
local
open
read
frame
orf
design
accord
convent
rosel
et
al
relev
orf
encod
polypeptid
predict
molecular
weight
mw
kda
product
gene
express
escherichia
coil
comigr
authent
polypeptid
kda
impli
observ
anomal
electrophoret
migrat
convent
gel
system
could
result
properti
polypeptid
due
posttransl
event
hela
mous
cell
maintain
nutrient
media
nm
consist
eagl
modifi
mem
gordon
et
supplement
fetal
bovin
serum
vaccinia
viru
strain
ihdw
temperaturesensit
mutant
propag
titrat
plaqu
assay
use
l
cell
respect
viru
high
puriti
obtain
infect
l
cell
centrifug
potassium
tartrat
gradient
previous
describ
stern
dale
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
carri
accord
laemmli
immunoblot
transfer
polypeptid
nitrocellulos
filter
perform
describ
towbin
et
al
antigen
reveal
mean
antibodi
mark
use
k
conjug
protein
icn
describ
batteig
et
al
modifi
wilton
et
al
polypeptid
surfac
vaccinia
particl
identifi
react
sulfonhydroxysuccinimid
ester
biotin
sulfonhsbiotin
pierc
use
modif
procedur
previous
describ
dictyostelium
discoideum
plasma
membran
ingal
et
al
goodloeholland
luna
purifi
virion
suspend
mm
nahep
ph
concentr
proteinml
react
min
ice
sulfonhsbiotin
concentr
mgml
termin
reaction
lysin
ad
final
concentr
biotinyl
viru
polypeptid
separ
sdspage
transfer
nitrocellulos
filter
materi
expos
fb
mm
trishcl
ph
mm
nacl
tbstw
hr
block
step
wash
three
time
tbstw
react
dilut
alkalin
phosphatasestreptavidin
complex
amersham
hr
wash
tbstw
biotinyl
protein
visual
use
alkalin
phosphatas
color
develop
system
describ
manufactur
biorad
antibodi
specif
separ
polyclon
antiserum
rais
rabbit
viral
envelop
compon
releas
gordon
et
al
use
affin
purif
ball
kovala
briefli
extract
purifi
viru
prepar
describ
wilton
et
separ
prepar
sdspage
use
fullwidth
comb
follow
electrophoresi
protein
transfer
nitrocellulos
band
correspond
local
stain
amido
black
excis
nitrocellulos
sheet
excis
strip
cut
small
piec
transfer
barrel
syring
subsequ
step
carri
draw
ml
appropri
buffer
syring
needl
mix
gentli
nitrocellulos
block
treat
phosphatebuff
salin
tween
pbstw
contain
casein
hr
nitrocellulos
piec
wash
extens
pbstw
six
eight
wash
react
antiserum
overnight
piec
wash
extens
pbstw
bound
antibodi
elut
min
glycin
ph
nacl
eluat
immedi
neutral
trishci
ph
dialyz
pb
concentr
immunoglobulln
protein
final
sampl
determin
method
lowri
et
al
protein
present
envelop
vaccinia
solubil
describ
previous
stern
dale
use
immun
balbc
mice
initi
immun
antigen
obtain
ug
viral
protein
administ
intraperiton
complet
freund
adjuv
two
booster
immun
administ
interv
suspens
splenocyt
prepar
day
last
inject
fuse
cell
myeloma
presenc
polyethylen
glycol
peg
iscov
modifi
dmem
imdm
contain
dmso
hybridoma
select
procedur
koehler
milstein
select
carri
hat
medium
cultur
fluid
hybridoma
coloni
develop
screen
antibodi
vaccinia
viru
polypeptid
mean
elisa
immunofluoresc
western
blot
establish
antibodyproduc
twice
clone
hybridoma
grown
intraperiton
syngen
mice
ascit
fluid
obtain
ig
fraction
purifi
ascit
fluid
hplc
use
deae
beckman
column
employ
sequenc
bind
buffer
mm
tri
hci
ph
mm
trishci
ph
na
acet
elut
buffer
neutral
viru
infecti
assay
plaqu
reduct
test
sampl
antiserum
monoclon
antibodi
mab
test
dilut
promin
antigen
surfac
polypeptid
pb
mix
standard
number
plaqu
form
unit
pfu
vaccinia
viru
final
volum
al
follow
incub
min
bind
antibodi
mixtur
serial
dilut
nm
appli
indic
monolay
l
cell
plaqu
assay
cyanogen
bromid
cnbr
cleavag
polypeptid
viral
protein
releas
method
stern
dale
mg
purifi
vaccinia
viru
protein
separ
sdspage
identifi
limit
stain
coomassi
blue
band
excis
destain
cut
piec
cm
length
sampl
react
rotari
mixer
room
temperatur
min
sequenti
step
ml
follow
solut
h
n
hci
n
hci
contain
mg
cnbr
two
wash
h
trishci
ph
equilibr
dissoci
buffer
use
sdspage
react
gel
piec
mw
marker
electrophores
duplic
sdspage
one
gel
stain
coomassi
blue
use
western
blot
analysi
antigen
identifi
virion
form
viru
intermedi
immunogold
label
reaction
carri
float
formvar
carbon
coat
grid
droplet
appropri
reagent
dilut
pb
contain
bovin
serum
albumin
pbsbsa
attach
viru
materi
film
grid
place
min
pbsbsa
block
nonspecif
bind
antibodi
primari
antibodi
dilut
desir
allow
react
min
remov
three
wash
min
pbsbsa
secondari
antibodi
goat
antirabbit
auantirabbit
goat
antimous
auantimous
conjug
nm
colloid
gold
particl
sigma
dilut
appli
min
grid
wash
pbsbsa
time
mm
hepe
ph
case
materi
neg
stain
use
phosphotungst
acid
pta
cytoplasm
lysat
vaccinia
viru
infect
cell
prepar
immunogold
em
modif
procedur
use
stern
dale
infect
monolay
scrape
cell
pellet
g
resuspend
mem
dilut
water
induc
swell
cell
lyse
repeatedli
time
forc
needl
syring
remain
intact
cell
larg
cell
debri
remov
centrifug
g
min
supernat
suspens
adjust
naci
stabil
osmot
sensit
structur
dilut
supernat
fraction
appli
em
grid
materi
fix
min
glutaraldehyd
pb
wash
pb
react
antibodi
manner
describ
polypeptid
expos
surfac
vaccinia
viru
identifi
biotinyl
intact
virion
use
sulfo
deriv
nhydroxysuccinimidobiotin
sulfonhsbiotin
agent
effect
transfer
biotin
primari
amin
notabl
e
group
lysin
residu
within
polypeptid
charg
sulfat
group
compound
prevent
penetr
compound
hydrophob
portion
membran
therebi
limit
reactiv
extern
expos
region
envelop
polypeptid
biotinyl
viru
subject
sdspage
follow
electrophoret
transfer
nitrocellulos
biotinyl
polypeptid
visual
reaction
strepintracellular
immunogold
label
intracellular
viru
compon
contain
local
immunolabel
describ
dale
et
al
monolay
hela
cell
grown
organ
cultur
dish
falcon
pretreat
polyllysin
enhanc
cell
attach
infect
vaccinia
viru
pfucel
cell
undergo
infect
wash
mm
napip
ph
mm
mgcl
mm
egta
nacl
pib
fix
min
freshli
prepar
paraformaldehyd
pib
permeat
exposur
three
chang
saponin
pib
pibss
min
pibss
remov
wash
twice
pib
primari
antibodi
either
mab
affin
purifi
rabbit
ig
dilut
pib
appli
room
temperatur
hr
remov
unadsorb
antibodi
wash
three
time
pib
appropri
secondari
antibodygold
conjug
dilut
ad
hr
five
wash
pib
cell
materi
fix
addit
glutaraldehyd
osmium
tetroxid
dehydr
grade
ethanol
seri
embed
epoxi
resin
mixtur
thin
section
prepar
stain
convent
method
tavidinalkalin
phosphatas
ap
complex
use
ap
color
develop
system
procedur
identifi
six
promin
polypeptid
molecular
weight
kda
fig
lane
deriv
comparison
biotinyl
marker
one
band
present
polypeptid
evid
lane
probabl
artifact
gel
system
authent
viral
polypeptid
travers
entir
gel
biotinyl
viru
polypeptid
separ
polyacrylamid
gel
addit
surfac
polypeptid
kda
evid
data
shown
compon
correspond
extern
polypeptid
describ
identif
western
blot
vaccinia
viru
antigen
associ
envelop
describ
previous
wilton
et
al
two
group
antigen
identifi
releas
neutral
deterg
alon
solubil
along
entir
envelop
plu
describ
pogo
dale
biotinyl
viru
surfac
polypeptid
separ
manner
extract
releas
bulk
polypeptid
deterg
phase
fig
lane
leav
behind
biotinyl
polypeptid
insolubl
pellet
fig
lane
antigen
equal
abund
solubl
insolubl
fraction
extract
virion
mm
envelop
disappear
leav
behind
core
attach
later
bodi
see
fig
prepar
polypeptid
appear
solubl
fraction
fig
lane
polypeptid
releas
alon
confus
similarli
migrat
polypeptid
describ
previous
wilton
et
latter
synthes
ihdw
strain
vaccinia
use
current
studi
present
ihdj
strain
react
nhsbiotin
data
shown
indic
polypeptid
also
surfac
expos
compon
one
note
faint
signal
biotinyl
polypeptid
remain
viral
core
fig
lane
slight
biotinyl
highli
abund
core
polypeptid
dale
pogo
could
due
presenc
minor
fraction
damag
virion
purifi
suspens
locat
promin
antigen
envelop
compar
duplic
sampl
mean
western
blot
surfacelabel
polypeptid
antigen
identifi
polyval
rabbit
antibodi
rais
compon
viral
envelop
releas
gordon
et
distribut
deterg
solubl
insolubl
fraction
detect
immunoblot
fig
b
ident
reveal
biotinyl
polypeptid
effici
solubil
achiev
compar
report
us
previous
wilton
et
probabl
due
carri
extract
ph
rather
use
start
materi
lower
concentr
mgml
viru
protein
among
minor
compon
observ
western
blot
employ
polyval
antibodi
antigen
migrat
faster
fig
comigr
biotinyl
polypeptid
fig
second
antigen
biotinyl
counterpart
data
locat
biotinyl
polypeptid
readi
solubil
came
evid
surfac
compon
correspond
detect
previous
mous
hyperimmun
sera
wilton
et
rabbit
serum
vaccinia
antigen
solubil
gordon
al
defin
antigen
affin
purifi
rabbit
antibodi
prepar
describ
materi
method
specif
antibodi
evid
immunoblot
analysi
illustr
fig
singl
promin
band
evid
obtain
approxim
estim
amount
monospecif
antibodi
affin
purif
relat
start
materi
serial
dilut
origin
rabbit
antiserum
react
standard
amount
vaccinia
antigen
compar
affinitypurifi
antibodi
fig
note
weak
addit
band
higher
mw
posit
also
evid
lane
correspond
reaction
purifi
nonpurifi
antibodi
minor
antigen
compon
may
result
retard
electrophoret
field
due
unreduc
dimer
contamin
associ
follow
excis
gel
reelectrophoresi
antigen
migrat
posit
data
shown
describ
similar
observ
made
mab
ascertain
whether
play
role
infect
earli
cellviru
interact
affinitypurifi
reduct
vaccinia
infecti
antienvelop
polyspecif
monospecif
rabbit
antibodi
either
pb
alon
vari
dilut
antisera
pb
incub
reaction
volum
hr
standard
number
pfu
vaccinia
viru
virusantibodi
complex
dilut
assay
l
cell
monolay
open
squar
antiserum
extract
close
squar
prelmmun
rabbit
serum
open
circl
affinitypurifi
monospecif
antibodi
close
circl
control
pb
monospecif
antibodi
test
neutral
assay
comparison
also
use
serum
direct
extract
virion
compon
evid
plaqu
reduct
data
seen
fig
optimum
dilut
polyval
serum
decreas
vaccinia
viru
infect
approxim
affinitypurifi
serum
preimmun
control
rabbit
serum
signific
effect
infect
describ
fig
level
reactiv
specif
also
evalu
western
blot
assess
compar
antibodi
reactiv
base
affin
sdsdenatur
antigen
data
estim
reactiv
pl
affinitypurifi
antibodi
correspond
approxim
obtain
ul
polyval
antiserum
suggest
reactiv
purifi
antibodi
could
severalfold
higher
actual
observ
neutral
assay
still
made
less
effici
polyval
serum
loss
potenc
may
occur
affin
purif
procedur
reli
immobil
antigen
western
blot
therefor
antibodi
releas
bind
must
primarili
linear
epitop
rather
addit
conform
epitop
possess
perhap
greater
signific
neutral
infecti
second
import
consider
presenc
serum
direct
entir
extract
antibodi
spectrum
antigen
interact
host
cell
surfac
includ
import
polypeptid
describ
rodriguez
et
al
defin
antigen
polypeptid
select
panel
mab
follow
immun
mice
vaccinia
viru
compon
extract
describ
materi
method
among
coloni
grew
cultur
prove
posit
vaccinia
antigen
elisa
andor
immunofluoresc
test
among
gave
signal
western
blot
affin
variabl
degre
mab
gave
strongest
signal
chosen
studi
although
extract
viru
three
promin
protein
band
usual
present
see
fig
antivaccinia
mab
select
find
attribut
either
abund
andor
effect
antigen
tabl
summar
character
select
purifi
monoclon
antibodi
reactiv
note
one
mab
test
found
igm
k
isotyp
degre
immunofluoresc
variabl
one
mab
test
show
appreci
capac
neutral
infect
specif
mab
give
strongest
reaction
immunofluoresc
western
blot
test
follow
purif
ascit
fluid
hplc
evid
fig
appli
materi
infect
cell
lane
pure
viru
lane
gave
strong
signal
specif
wherea
uninfect
cell
lysat
neg
lane
view
frequenc
mab
occur
select
wish
ascertain
whether
particular
domain
antigen
immunogen
preferenti
polypeptid
could
broken
select
fragment
cnbr
amino
acid
sequenc
three
intern
methionin
avail
cleavag
fragment
deriv
cnbrdigest
purifi
describ
materi
method
resolv
page
separ
graphic
present
show
locat
ntermin
intern
methionin
predict
sequenc
gordon
et
al
possibl
peptid
deriv
therefrom
provid
fig
compar
actual
peptid
resolv
page
stain
coomassi
blue
fig
bind
mab
reveal
immunoblot
fig
due
anomal
migrat
base
sequenc
data
kda
rather
kda
gordon
et
al
possibl
predict
exact
mw
individu
peptid
obtain
cnbr
cleavag
howev
possibl
relat
diminut
mw
consequ
remov
one
fragment
evid
data
tabl
cnbrfragment
mw
obtain
gel
fig
match
close
predict
sequenc
intact
cb
fragment
appar
mw
fig
tabl
kda
greater
predict
sequenc
therefor
anomal
migrat
page
must
due
sequenc
motif
resid
limit
digest
peptid
cb
repres
fragment
common
peptid
show
anomal
migrat
promin
band
fig
could
cleavag
degrad
product
one
larger
fragment
affin
mab
cnbr
peptid
reveal
fig
evid
antibodi
identifi
epitop
fragment
cb
three
mab
among
test
show
bind
pattern
data
shown
indic
contain
highli
immunogen
sequenc
similar
western
blot
util
monospecif
rabbit
antibodi
describ
hyperimmun
antisera
mice
immun
whole
vaccinia
viru
wilton
et
al
gave
ident
similar
affinitylabel
pattern
cb
fragment
data
shown
result
confirm
import
antigen
domain
analysi
comput
program
probabl
antigen
determin
reveal
fig
high
correl
predict
region
amino
acid
sequenc
fragment
presenc
envelop
determin
releas
well
presenc
promin
surfac
reactiv
biotinyl
polypeptid
kda
suggest
least
part
expos
confirm
assumpt
ascertain
whether
distribut
randomli
specif
loci
viru
surfac
react
highli
purifi
intact
virion
antibodi
mark
antibodi
immunoglobulincolloid
gold
conjug
extens
label
entir
surfac
virion
obtain
mab
fig
appar
increas
concentr
gold
particl
near
perimet
virion
often
evid
like
due
natur
em
imag
devereux
al
plot
analys
illustr
note
box
region
span
fragment
residu
indic
map
antigen
determin
show
high
degre
correl
predict
region
three
paramet
parallel
experi
conduct
affinitypurifi
monospecif
antibodi
also
show
specif
bind
surfac
virion
whole
mount
fig
thin
section
fig
wherea
rabbit
antiserum
tubulin
chicken
gift
dr
e
ball
depart
biochemistri
univers
westem
ontario
use
control
label
surfac
vaccinia
data
shown
follow
treatment
purifi
vaccinia
viru
viral
envelop
remov
leav
behind
intact
viral
core
associ
later
bodi
pogo
dale
expos
strip
viru
mab
number
gold
particl
evid
small
fraction
less
present
intactvirion
compar
fig
gold
particl
fig
could
due
specif
bind
antibodi
residu
fragment
envelop
well
nonspecif
label
specif
associ
envelop
matur
virion
confirm
mean
immunotag
infect
cell
use
permeat
antibodi
saponin
intracytoplasm
virion
surfac
becam
coat
antibodi
identifi
presenc
gold
particl
fig
howev
virion
releas
cell
wrap
membran
deriv
golgi
host
cell
dale
pogo
label
fig
absenc
label
shroud
virion
indic
total
absenc
surfac
wrap
membran
also
demonstr
inabl
antibodi
penetr
enclos
membran
sinc
monospecif
rabbit
mab
direct
avidli
bound
surfac
predict
prior
bind
one
specif
antibodi
interfer
bind
secondarili
observ
mw
determin
comparison
migrat
molecular
weight
marker
coelectrophores
cnbr
digest
predict
mw
fragment
deriv
sequenc
gordon
er
al
differ
mw
fragment
estim
sdspage
predict
dna
sequenc
n
mean
indic
band
observ
perhap
peptid
migrat
beyond
limit
gel
appli
antibodi
relev
epitop
ident
close
contigu
virion
react
quantit
analysi
monospecif
rabbit
antibodi
first
mab
rel
amount
mab
antibodi
surfac
estim
count
gold
particl
randomli
select
virion
primari
applic
rabbit
antibodi
decreas
factor
number
gold
particl
identifi
mab
tabl
howev
achiev
degre
competit
requir
use
high
concentr
rabbit
antibodi
impli
mabwa
present
excess
confirm
competit
experi
employ
primari
bind
constant
amount
rabbit
antibodi
follow
rang
dilut
mab
procedur
result
effect
competit
rabbit
antibodi
use
compet
ng
mab
shown
data
tabl
competit
constant
amount
rabbit
antibodi
ngul
mab
reduc
bind
approxim
valu
similar
obtain
rabbit
primari
antibodi
ngul
mab
ngpl
see
tabl
data
indic
mab
outcompet
affinitypurifi
rabbit
antibodi
close
posit
site
virion
surfac
absenc
either
antibodi
background
bind
auantimous
vaccinia
viru
neglig
background
slightli
higher
presenc
compet
rabbit
antibodi
creas
background
could
due
minor
crossreact
goat
antimous
ig
rabbit
antibodi
effici
competit
bind
antibodi
differ
sourc
confirm
stringenc
local
surfac
virion
immunogold
techniqu
associ
vaccinia
envelop
viru
develop
took
advantag
procedur
introduc
antibodi
infect
cell
permeat
cell
membran
determin
whether
present
envelop
form
stage
well
matur
particl
although
permeat
individu
cell
cultur
mean
saponin
highli
variabl
exampl
found
tag
mab
monospecif
rabbit
antibodi
goldantibodi
conjug
adequ
demonstr
thin
section
specif
bind
immatur
form
vaccinia
one
exampl
virusinfect
cell
sampl
hr
inocul
numer
immatur
virion
label
gold
particl
evid
cytoplasm
fig
intermedi
envelop
assembl
possess
characterist
rigid
spiculeback
hemispher
conform
also
specif
label
evid
exampl
shown
fig
reactiv
frequent
evid
free
end
segment
envelop
spiculeback
membran
structur
termin
suggest
specif
antibodi
becam
attach
bilay
structur
envelop
fig
quit
possibl
extern
layer
spicul
describ
detail
previous
essani
et
al
hindranc
readi
access
antibodi
subjac
bilay
gold
particl
present
within
nonmembran
viroplasm
matrix
materi
specif
antigenantibodi
interact
shown
absenc
gold
particl
mab
direct
variabl
surfac
glycoprotein
trypanosoma
bruceii
gift
dr
w
clark
depart
microbiolog
univers
western
ontario
use
control
data
shown
sinc
known
earli
polypeptid
synthes
despit
inhibit
dna
replic
hu
gordon
al
drug
caus
arrest
viru
assembl
envelop
immatur
particl
stage
pogo
dale
use
drug
ascertain
whether
occur
immatur
virion
immatur
virion
releas
cell
either
treat
hu
untreat
infect
intact
particl
subject
label
gold
conjug
manner
use
isol
matur
vaccinia
found
antibodi
becam
attach
immatur
viru
particl
regardless
whether
origin
control
hutreat
cell
fig
result
demonstr
inde
compon
envelop
associ
membran
bilay
envelop
also
investig
mean
temperaturesensit
mutant
tsl
vaccinia
restrict
temperatur
envelop
mutant
assembl
flexibl
bilay
lack
attach
extern
spicul
layer
membran
sheet
surround
viroplasm
assembl
site
within
cytoplasm
order
determin
whether
could
close
associ
free
membran
situ
trace
immunogold
carri
permeabil
cell
infect
l
hr
result
exemplifi
illustr
fig
demonstr
rabbit
monospecif
antibodi
becam
bound
predominantli
membran
structur
surround
foci
viroplasm
observ
support
conclus
intim
compon
membran
bilay
envelop
new
data
deriv
present
studi
character
promin
vaccinia
viru
antigen
gordon
al
respect
involv
structur
format
viru
local
mean
biotinyl
surfac
polypeptid
immunoelectron
microscopi
reveal
unambigu
locat
extern
surfac
envelop
surfac
label
studi
confirm
extend
work
sarov
joklik
use
radioiodin
identifi
surfac
expos
vaccinia
polypeptid
use
nhsbiotin
type
probe
surfac
polypeptid
one
major
advantag
use
radioiodin
target
amino
acid
tyrosin
nhsbiotin
react
primari
amino
group
notabl
group
lysin
much
preval
wide
distribut
amino
acid
protein
sarov
joklik
observ
strong
signal
correspondproduc
treatment
react
mab
auantimous
e
thin
section
infect
hela
cell
illustr
two
virion
near
surfac
cell
monolay
react
mab
follow
auantimous
note
high
concentr
gold
particl
surfac
one
vaccinia
particl
absenc
label
virion
enclos
wrap
membran
arrow
cy
cytoplasm
magnif
b
c
e
bar
repres
ing
lowmw
polypeptid
design
migrat
kda
well
weaker
signal
like
correspond
biotinyl
polypeptid
report
present
studi
investig
identifi
four
addit
surfac
expos
polypeptid
migrat
kda
surfac
polypeptid
probabl
correspond
compon
surfac
tubular
element
ste
stern
dale
unlik
solubil
alon
ste
releas
entir
envelop
dismemb
extract
local
structur
term
viral
envelop
dale
pogo
confirm
immunogold
label
intact
virion
use
affin
purifi
antibodi
deriv
polyclon
antiserum
direct
envelop
compon
releas
mab
react
specif
immunogold
label
vaccinia
envelop
confirm
thin
section
reveal
absenc
antigen
reactiv
wrap
extracellular
form
virion
result
demonstr
antibodi
unabl
penetr
bilay
wrap
membran
furthermor
absenc
reactiv
virion
releas
exocytosi
becom
wrap
membran
deriv
golgi
dale
show
compon
membran
cellular
origin
neutral
vaccinia
infect
either
affinitypurifi
rabbit
monospecif
antibodi
mab
direct
suggest
polypeptid
particip
intim
cellviru
interact
surprisingli
polyval
affinitypurifi
antibodi
could
diminish
infecti
effici
approxim
origin
valu
mab
sinc
affinitypurifi
serum
would
like
react
one
epitop
polypeptid
neutral
observ
polyclon
antienvelop
serum
much
effect
monospecif
antibodi
indic
suppress
infecti
sever
polypeptid
antigen
probabl
particip
rel
low
effici
plaqu
reduct
test
monospecif
rabbit
antibodi
keep
neutral
data
obtain
use
antibodi
vaccinia
envelop
polypeptid
rodriguez
may
consequ
larg
surfac
area
antigen
complex
viru
addit
ineffici
neutral
mab
monospecif
antibodi
may
indic
sever
polypeptid
play
role
initi
stage
infect
consequ
specif
immunogold
tag
could
examin
involv
polypeptid
develop
viral
envelop
identifi
earli
protein
gordon
et
al
therefor
one
synthes
even
absenc
viral
dna
synthesi
block
hydroxyurea
thu
differ
class
vaccinia
envelop
polypeptid
fusogen
protein
describ
cell
surfacebind
polypeptid
nile
seto
maa
et
al
ste
compon
describ
dale
late
protein
tempor
distinct
regul
express
wholli
compat
mechan
assembl
vaccinia
envelop
intracytoplasm
local
immun
electron
microscopi
develop
vaccinia
particl
infect
hela
cell
fix
permeabil
react
affinitypurifi
monospecif
antibodi
follow
auantirabbit
describ
materi
method
portion
cytoplasm
also
shown
b
c
higher
magnif
illustr
intermedi
viru
format
cell
infect
hr
note
spheric
shape
envelop
possess
extern
layer
spicul
arrowhead
note
also
c
present
short
segment
envelop
free
end
section
cytoplasm
hela
cell
infect
hr
vaccinia
react
ac
gold
particl
abund
near
membran
surround
viroplasm
area
e
whole
mount
neg
stain
immatur
virion
isol
cell
infect
hr
presenc
mm
hu
prepar
react
grid
mab
auantimous
magnif
b
c
e
barrepres
proce
complex
seri
step
commenc
prior
onset
viral
dna
synthesi
format
segment
membran
bilay
back
spicul
identifi
immatur
spheric
vaccinia
form
presenc
hu
pogo
dale
illustr
particip
earliest
phase
envelop
assembl
normal
assembl
process
nucleoprotein
materi
accumul
viroplasm
foci
undergo
complex
differenti
matur
virion
within
envelop
addit
late
step
assembl
vaccinia
virion
replac
spicul
layer
ste
characterist
matur
envelop
dale
pogo
appar
late
surfac
polypeptid
incorpor
time
viru
matur
part
envelop
throughout
viru
develop
morphogenesi
sever
vaccinia
mutant
attach
extern
spicul
layer
onto
envelop
fail
occur
consequ
accumul
flexibl
pleomorph
membran
surround
viroplasm
foci
demonstr
associ
membran
domain
immatur
virion
reveal
normal
develop
inde
associ
envelop
bilay
spicul
mechan
integr
vaccinia
polypeptid
envelop
bilay
appear
distinct
occur
convent
envelop
virus
date
none
recogn
vaccinia
envelop
polypeptid
dna
sequenc
data
avail
among
fusion
protein
compon
nile
seto
maa
et
al
gordon
et
al
possess
aminotermin
hydrophob
signal
sequenc
involv
insert
bilay
membran
although
vaccinia
virion
contain
two
glycoprotein
none
present
envelop
holowczak
garon
moss
absenc
envelop
glycoprotein
vaccinia
contrast
envelop
virus
consequ
synthesi
envelop
protein
cytosol
rather
endoplasm
reticulum
henc
integr
nascent
polypeptid
must
occur
subsequ
synthesi
cotransl
event
detail
integr
envelop
yet
clarifi
although
ctermin
portion
polypeptid
hydrophob
gordon
et
al
devoid
convent
transmembran
segment
compos
sole
hydrophob
amino
acid
analys
either
thegor
gamier
atal
gamier
robson
protocol
indic
term
secondari
structur
hydrophob
portion
possess
ahel
configur
model
helic
region
fig
becom
clear
amphipath
wherebi
select
hydrophob
amino
acid
occur
one
side
helix
provid
site
interact
lipid
bilay
polar
charg
amino
acid
occur
opposit
side
helix
involv
amphipath
helic
lipid
bilay
structur
analog
model
present
review
von
heijn
consid
two
type
interact
membran
either
homoor
heterodim
two
helic
simultan
span
membran
hydrophil
portion
helic
orient
inward
away
hydrophob
portion
lipid
monom
float
membran
surfac
hydrophob
portion
insert
within
membran
latter
model
fit
associ
myelin
basic
protein
myelin
membran
mendz
et
al
one
interest
characterist
anomal
migrat
sdspage
although
polypeptid
migrat
posit
correspond
kda
open
read
frame
orf
encod
suffici
encod
polypeptid
kda
discrep
anticip
rosel
etal
length
orf
inconsist
due
posttransl
modif
polypeptid
sinc
orf
link
prokaryot
promot
express
e
colyield
polypeptid
retain
anomal
migrat
examin
behavior
cnbr
cleavag
product
sdspage
becam
clear
fragment
contain
peptid
cb
correspond
unit
peptid
span
region
methionin
residu
el
aeirahlknsa
predict
amino
acid
sequenc
see
fig
found
posit
kda
larger
anticip
dna
sequenc
peptid
contain
fragment
posit
correctli
accord
predict
mw
within
stretch
amino
acid
residu
prolin
occur
consist
explan
suggest
gordon
et
al
caus
anomal
mw
polypeptid
sdspage
